Literature DB >> 2170388

Phosphorylation of smooth muscle caldesmon by calmodulin-dependent protein kinase II. Identification of the phosphorylation sites.

M Ikebe1, S Reardon.   

Abstract

Smooth muscle caldesmon was phosphorylated by smooth muscle calmodulin-dependent protein kinase II. The extent of phosphorylation obtained was 5.65 mol of phosphate/mol of caldesmon. Phosphorylated protein was subjected to the complete trypsin proteolysis and the produced phosphopeptides were purified by C-8 reverse phase chromatography. Nine phosphopeptides were isolated and by amino acid sequence analysis, eight phosphorylation sites were identified. According to the published amino acid sequence of chicken gizzard caldesmon (Bryan, J., Imai, M., Lee, R., Moore, P., Cook, R. G., and Lin, W.-G. (1989) J. Biol. Chem. 264, 13873-13879), these sites were serine 26, serine 59, serine 73, threonine 469, serine 475, serine 587, serine 620, and serine 726. The time course of phosphorylation of these sites was also measured and it was concluded that the first site was serine 73, the second site was serine 26, the third site was serine 726, and the fourth site was serine 587. The preferred phosphorylation sites were located in the amino terminus myosin binding domain whereas slower phosphorylation occurred in the carboxyl terminus actin/calmodulin domain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170388

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Smooth muscle caldesmon modulates peristalsis in the wild type and non-innervated zebrafish intestine.

Authors:  J Abrams; G Davuluri; C Seiler; M Pack
Journal:  Neurogastroenterol Motil       Date:  2012-03       Impact factor: 3.598

2.  Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmon-mediated inhibition of actin filament velocity.

Authors:  Z Wang; H Jiang; Z Q Yang; S Chacko
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Identification of functioning regulatory sites and a new myosin binding site in the C-terminal 288 amino acids of caldesmon expressed from a human clone.

Authors:  P A Huber; C S Redwood; N D Avent; M J Tanner; S B Marston
Journal:  J Muscle Res Cell Motil       Date:  1993-08       Impact factor: 2.698

4.  Phosphorylation by casein kinase II affects the interaction of caldesmon with smooth muscle myosin and tropomyosin.

Authors:  N V Bogatcheva; A V Vorotnikov; K G Birukov; V P Shirinsky; N B Gusev
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

5.  New isoforms of Ca2+/calmodulin-dependent protein kinase II in smooth muscle.

Authors:  Z L Zhou; M Ikebe
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

6.  Phosphorylation of caldesmon by smooth-muscle casein kinase II.

Authors:  C Sutherland; B S Renaux; D J McKay; M P Walsh
Journal:  J Muscle Res Cell Motil       Date:  1994-08       Impact factor: 2.698

Review 7.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

8.  Reversal of caldesmon binding to myosin with calcium-calmodulin or by phosphorylating caldesmon.

Authors:  M E Hemric; F W Lu; R Shrager; J Carey; J M Chalovich
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

Review 9.  Smooth muscle signalling pathways in health and disease.

Authors:  H R Kim; S Appel; S Vetterkind; S S Gangopadhyay; K G Morgan
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

10.  Smooth-muscle caldesmon phosphatase is SMP-I, a type 2A protein phosphatase.

Authors:  M D Pato; C Sutherland; S J Winder; M P Walsh
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.